Bone marrow dosimetry in peptide receptor radionuclide therapy with [(177)Lu-DOTA(0),Tyr(3)]octreotate

PURPOSE: Adequate dosimetry is mandatory for effective and safe peptide receptor radionuclide therapy (PRRT). Besides the kidneys, the bone marrow is a potentially dose-limiting organ. The radiation dose to the bone marrow is usually calculated according to the MIRD scheme, where the accumulated act...

Descripción completa

Detalles Bibliográficos
Autores principales: Forrer, Flavio, Krenning, Eric P., Kooij, Peter P., Bernard, Bert F., Konijnenberg, Mark, Bakker, Willem H., Teunissen, Jaap J. M., de Jong, Marion, van Lom, Kirsten, de Herder, Wouter W., Kwekkeboom, Dik J.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691529/
https://www.ncbi.nlm.nih.gov/pubmed/19247653
http://dx.doi.org/10.1007/s00259-009-1072-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691529/
https://www.ncbi.nlm.nih.gov/pubmed/19247653
http://dx.doi.org/10.1007/s00259-009-1072-6

Ejemplares similares